Mutations of the BRAF (B-Raf, B-rapidly accelerated fibrosarcoma) serine-threonine kinase are associated with poor prognoses in melanoma, colorectal cancer (CRC), non-small cell lung cancer (NSCLC), and other cancers[1]. This evidence concerns the gene BRAF and melanoma.